Topic

Michigan

A collection of 444 issues

How to Get Alecensa (alectinib) Covered by Aetna CVS Health in Michigan: Complete Guide to Prior Authorization and Appeals

Quick Answer: Getting Alecensa (alectinib) Covered by Aetna CVS Health in Michigan Aetna CVS Health requires prior authorization for Alecensa (alectinib), an ALK inhibitor for non-small cell lung cancer. Your fastest path to approval: Submit the PA request with ALK-positive test results, prior therapy documentation, and medical necessity letter through
5 min read

Renewing Brineura (Cerliponase Alfa) Coverage with Aetna in Michigan: Timeline, Documentation & Appeal Process

Answer Box: Renewing Brineura Coverage with Aetna in Michigan Start your Brineura renewal 60-90 days before expiration. Aetna requires updated clinical documentation showing motor function scores ≥1 on the CLN2 Clinical Rating Scale, plus physician notes demonstrating ongoing treatment benefit. Submit renewal through your prescribing neurologist or specialty center. If
5 min read

Getting Hemgenix (etranacogene dezaparvovec) Approved by Humana in Michigan: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Hemgenix Covered by Humana in Michigan Eligibility: Adults 18+ with severe/moderately severe hemophilia B, negative inhibitor test, 150+ Factor IX exposure days, and current prophylaxis. Fastest approval path: Submit complete prior authorization with hematologist letter, bleeding history, and lab results through Humana provider portal. Start today:
5 min read

How to Get Vanflyta (Quizartinib) Covered by Humana in Michigan: Complete Coding, Appeals, and Prior Authorization Guide

Answer Box: Getting Vanflyta Covered by Humana in Michigan Vanflyta (quizartinib) requires prior authorization from Humana for FLT3-ITD positive acute myeloid leukemia. Key requirements: FLT3-ITD test results, baseline EKG, and oncologist prescription. First step: Gather FLT3-ITD lab report and submit Humana's prior authorization form through their provider portal.
6 min read

How to Get Hetlioz LQ (tasimelteon oral suspension) Covered by UnitedHealthcare in Michigan: Appeals Guide & Templates

Answer Box: Getting Hetlioz LQ Covered by UnitedHealthcare in Michigan Fast Track to Approval: UnitedHealthcare requires prior authorization for Hetlioz LQ (tasimelteon oral suspension) for pediatric Smith-Magenis syndrome patients ages 3-15. You need genetic testing confirming SMS diagnosis, specialist involvement, and documented sleep disturbances. If denied, you have internal appeals
6 min read